Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies

Stopped early · Phase 3

Conditions studied: Hepatitis C Virus Infection

In brief

The primary objective of this study is to evaluate the efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed dose combination (FDC) for 12 weeks with or without ribavirin (RBV) in participants without cirrhosis, and LDV/SOF FDC for 12 weeks with RBV or LDV/SOF FDC for 24 weeks without RBV in participants with cirrhosis.

Key facts

Study ID

NCT02600351

Run by

Gilead Sciences

People needed

87

Starts

2015-11-11

Expected to finish

2017-05-29

Last updated by the study team

2018-11-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Little Rock, Arkansas, United States
• Study site — Los Angeles, California, United States
• Study site — Pasadena, California, United States
• Study site — Rialto, California, United States
• Study site — Sacramento, California, United States
• Study site — Ventura, California, United States
• Study site — New Haven, Connecticut, United States
• Study site — Largo, Florida, United States
• Study site — Weston, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Skokie, Illinois, United States
• Study site — Baltimore, Maryland, United States
• Study site — Columbia, Maryland, United States
• Study site — Worcester, Massachusetts, United States
• Study site — Saint Paul, Minnesota, United States
• Study site — Kansas City, Missouri, United States
• Study site — St Louis, Missouri, United States
• Study site — Egg Harbor, New Jersey, United States
• Study site — New York, New York, United States
• Study site — New York, New York, United States
• Study site — The Bronx, New York, United States
• Study site — Chapel Hill, North Carolina, United States
• Study site — Charlotte, North Carolina, United States
• Study site — Durham, North Carolina, United States
• Study site — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.